DOCSLIB.ORG

Investor Day

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Investor Day Investor Day November 15, 2019 Investor Relations [email protected] FOR INVESTOR USE ONLY Agenda 1. Our Strategy 7. Interventional Solutions Dow Wilson, President & Chief Executive Officer Gary Bischoping, President, Interventional Solutions* Frank Facchini, M.D., Chief Medical Officer, 2. Oncology Systems Interventional Solutions Chris Toth, President, Oncology Systems 8. Financial Update Gary Bischoping, President, Interventional Solutions* 3. CTSI J. Michael Bruff, Chief Financial Officer* Andrew Shogan, SVP, CTSI 9. Q&A 4. Software Solutions Corey Zankowski, Ph.D., SVP, Oncology Software Solutions 10. Closing Remarks Dow Wilson, President & Chief Executive Officer 5. Break 6. Proton Solutions & Emerging Businesses Kolleen T. Kennedy, President, Proton Solutions and Chief Growth Officer Dee Khuntia, M.D., Chief Medical Officer 2 FOR© 2019. INVESTOR Varian Medical USE ONLY Systems, Inc. For immediate recipient only. *Effective December 1, 2019 Overview & Strategy Dow Wilson, President & Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking Statements Except for historical information, this presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including growth drivers, future trends in cancer incidence and trends in cancer treatment needs, demand, innovation and growth opportunities; Varian Medical System, Inc.’s (”Varian” or the “company”) future orders, revenues, backlog earnings or cash flow growth or trends; future financial results; market acceptance of or transition to new products or technology such as our Edge® radiosurgery system, TrueBeam®, HyperArcTM, 360 OncologyTM, HALCYONTM, BRAVOSTM, EthosTM, image-guided radiation therapy, stereotactic radiosurgery, proton therapy, and interventional oncology products, and any statements using the terms “could”, “believe”, “expect”, “outlook”, “anticipate”, ”vision”, “estimate”, “future”, “horizon”, “aiming”, “driving”, “target” or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company’s actual results to differ materially from those anticipated. Such risks and uncertainties include global economic conditions and changes to trends for cancer treatment regionally; new and potential future tariffs or a global trade war; the impact of changes to the Affordable Health Care for America Act (including excise taxes on medical devices) and any further healthcare reforms (including changes to Medicare and Medicaid), and/or changes to third-party reimbursement levels; currency exchange rates and tax rates; the impact of the Tax Cuts and Jobs Act; demand for the company’s products; the company’s ability to develop, commercialize, and deploy new products; the company’s ability to meet Food and Drug Administration (FDA) and other regulatory requirements for product clearances or to comply with FDA and other regulatory regulations or procedures, changes in the regulatory environment, including with respect to FDA requirements; the company’s assessment of the goodwill associated with its proton business, challenges associated with the successful commercialization of the company’s proton business; the risks associated with providing financing for the construction and start-up operations of proton therapy centers; the effect of adverse publicity; the company’s reliance on sole or limited-source suppliers; the company’s ability to maintain or increase margins; the impact of competitive products and pricing; the potential loss of key distributors or key personnel; challenges to public tender awards and the loss of such awards or other orders; and the other risks listed from time to time in the company’s filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this presentation because of new information, future events, or otherwise. Reconciliations to GAAP financials can be found in our earnings press releases at www.varian.com/investors. Medical Advice Disclaimer Varian as a medical device manufacturer cannot and does not recommend specific treatment approaches. Individual treatment results may vary. 4 FOR INVESTOR USE ONLY Since our last investor day Confidence in our long-term strategy 2019: Global Leader in Radiation Therapy, AND 2017: Global Leader in Radiation Therapy Building a Multi-Modality Cancer Company 2% 3Y Oncology $2.6B 8% 3Y Oncology $3.2B 23%* Orders CAGR FY17 Revenue Orders CAGR FY19 Revenue 7,800+ 4,500+ 8,500+ 9%* 5,500+ 22%* Linac Installed Base Software Installs Linac Installed Base Software Installs 2.8M 75 4M+ 40%+* 79 Patients Touched NPS Score** Patients Touched NPS Score** Oncology Systems Proton Therapy Oncology Systems Proton Solutions Interventional Oncology Software Solutions Solutions Chief Growth Office 5 FORVARIAN INVESTOR CONFIDENTIAL USE ONLY – INTERNAL USE ONLY Note: Data as of FY2017, excluding Varex. Focus driving strong operational execution * Comparison of FY19 to FY17 ** According to IMV ServiceTrak in U.S. Radiation Oncology Systems Report 70 years of leadership in medical technology Varian Medical Systems Created Introduced TrueBeam system for radiotherapy Spin-off of Varian and radiosurgery Semiconductor Varex spin-off Equipment Associates & Varian, Inc. 2017 Varian Associates Introduced first linac 2010 2016 Founded 1999 Silicon Valley 1.0 company 1960 1948 Strategy Assessment Where can we make the biggest impact? Edward Russell Sigurd William How can we generate Ginzton Varian Varian Hansen co-founded above market growth BS, Stanford Pilot with first linear Varian with University Pan American accelerator, the brothers in and long-term value? 1925 Airways circa 1949 1948 6 FORFOR INVESTOR INVESTOR USE USE ONLY ONLY Cancer burden is growing = 500,000 of every 24.6 two million 13.6 cases 1males million and cases of every three 1females will have cancer 2010 2030 at some point in their lives* FOR INVESTOR USE ONLY 7 Source:FOR INVESTOR International USE Agency ONLY for Research on Cancer 2018. *American Cancer Society, Cancer Facts and Figures, 2012. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Accelerate growth across radiation therapy Expand the market What keeps us up at night… How Varian can solve this challenge… ~22,000* Exponentially improve access to care Linacs needed by 2035, with greatest need in low and mid-income countries ▪ Simplify, automate, human-centered design ▪ Lower cost of adoption 90% ▪ Combine people, data and technology to of patients don’t have access to RT in low improve treatment quality income countries ▪ Leverage AI to augment clinicians and amplify resources ~150K RT specialists needed globally by 2035 8 FOR INVESTOR USE ONLY *8,700 new machines plus 13,100 replacements = 21,800 additional machines needed Source: Expanding global access to radiotherapy. Lancet Oncol. Vol 16, Sept. 2015 Key trends impacting the future of cancer care Increased survivorship Earlier diagnosis Leverage evidence-based clinical Leading to increased curative therapy data to drive care evolution Managing costs Genomics Driving value-based care Driving personalized care and treatment Multi-disciplinary care Immunotherapy Moving towards the “care Enhancing impact through team approach” combination therapy Personalized treatment 9 FORVARIAN INVESTOR CONFIDENTIAL USE ONLY – INTERNAL USE ONLY Delivering guideline driven, multi- modality precision treatments Innovation in cancer driving increase in survival Varian believes a world without fear of cancer is on our horizon 1977 1987 1997 2007 Today >10 Years Driving Trends Prostate 99.9% 570K cases Breast 99% ✓ Earlier Diagnosis 868K cases Colorectal 91% ✓ New Treatments 704K cases Lung 38% 948K cases Liver 29% 403K cases Impact Pancreatic 17% 176K cases ✓ Increased Survivorship 0% 20% 40% 60% 80% 100% 5 year overall survival *Forecasted survival rate based on increases in treatment efficacy (Phase 2/3 data) and liquid biopsy availability. Artificial lungs, livers, and pancreas are under development but are not expected to be commercialized by 2027. 10 FORVARIAN INVESTOR CONFIDENTIAL USE ONLY – INTERNAL USE ONLY Sources: Survival Data: (1) National Cancer Institute’s SEER*Stat 8.3.4 databases, (2) Genomic Health Clinical Validation Trials, (3) Roche IMpassion 130 trial, additional on file Pivoting to a new way to fight cancer Build Expand Leverage Medical Oncology Radiation Oncology Surgical & Oncology Immuno Innovate Add new Software therapy Software RO Proton Proton radiotherapy to modalities to and cloud to Equip grow revenue touch more coordinate Interventional Services Oncology Software Equip patients cancer care Services Provider- Integrate artificial Based Tech-Enabled Services Services intelligence and machine learning Diagnosis capabilities ~5 2017 Years Horizon 1 Horizon 2 Global radiation Multimodal cancer therapy leader company 11 FORFOR INVESTOR INVESTOR USE USE ONLY ONLY Intelligent Cancer Care™ Approach Investing in innovation ~$1.5B Total organic and inorganic investment over 4 years Building strength in multi- >50% >1000 >200 disciplinary cancer care Headcount R&D Active invested in engineers patents software >120 13 Active clinical Countries collaborations with R&D 12 FOR© 2019. INVESTOR Varian Medical USE ONLY Systems, Inc. For immediate recipient only.. Pioneering and
Load more

Recommended publications
  • Edward Ginzton
    NATIONAL ACADEMY OF SCIENCES EDWARD LEONARD GINZTON 1915–1998 A Biographical Memoir by ANTHONY E. SIEGMAN Any opinions expressed in this memoir are those of the author and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoirs, VOLUME 88 COPYRIGHT 2006 NATIONAL ACADEMY OF SCIENCES WASHINGTON, D.C. Photograph by Lars Speyder EDWARD LEONARD GINZTON December 27, 1915–August 13, 1998 BY ANTHONY E. SIEGMAN DWARD L. GINZTON’S MULTIFACETED career spanned an era E of immense technological advances in physics, electronics, and microwaves—and of important advances in social and political issues. Throughout his long and productive life his remarkable combination of scientific skills, leadership quali- ties, technological foresight, and community concerns en- abled him to make distinguished technical contributions and to build enduring institutions in which others could make such contributions as well. Ginzton’s scientific career began in the late 1930s when he helped develop the understanding of feedback in early vacuum tube amplifiers and worked with the pioneers who invented the klystron. It continued through his leadership in developing modern microwave technologies and mega- watt-level klystron tubes during and after World War II, and in helping make possible the development of linear elec- tron accelerators both as mile-long “atom smashers” and as medical tools still in use worldwide for cancer radiation therapy. His abilities eventually led him to take distinguished roles in both the academic and industrial worlds and in local and national community service as well. 3 4 BIOGRAPHICAL MEMOIRS By the end of his career Ginzton held some 50 funda- mental patents in electronics and microwave devices, had received the 1969 IEEE Medal of Honor “for his outstand- ing contributions in advancing the technology of high power klystrons and their applications, especially to linear particle accelerators,” and had been elected to the National Acad- emy of Sciences (1966) and the National Academy of Engi- neering(1965).
    [Show full text]
  • History of HEPL Hansen Experimental Physics Laboratory
    History of HEPL Hansen Experimental Physics Laboratory going away party before demolition November 5, 2007 (prepared by Blas Cabrera with information from Stanford News archives and web) STANFORD UNIVERSITY A To Foothill Expressway I R JUNIP A ERO M SE To Interstate 280 via Page Mill Rd RRA A BLV T D N G A ERON S A RD ESTUDILLO RD SANT MIR A YNE ADA Z ST AVE D Hanna R House EL ESCARPADO S CA ' BRI N LLO A AVE Lou Henry M L T H Hoover House E C C A To N O F T E S Golf Course D A A N S R J A U R A S F N E R N R A C A O O V L S L O O A D K S E MAYFIELD AVE C Y To Interstate 280 ON L ST S N AN AN via Alpine Rd ZO JU V S AN E AL T PAR L or Sand Hill Rd V AI O WY A SO M A T AD S IT AN T S Row PL SA A ES L VAT A Hsg C O IER E T D RA E Off The A S V Knoll N T I M R O AY R T F D L S IE LAGUNITA O AN LD S C E Z A U South B E VE N P Golf Driving Range A Y M RD LV A A Residences Elliott L AR T C Program IL A N Pearce H DO A Center E SAN S Mitchell L N RO O PI FRANCISCO SF TER W Houses Florence M IT CT Moore Hall A D Tennis AVE R Huston MAYFIELD Bechtel Courts T House Int’l o S Center ta Cowell Bolivar Serra Governor’s Corner n N ELECTIONEER fo Cowell L House rd Student Roble LANE L A Cluster L Faculty ve L Health Owen Mariposa R Hall Red Houses E B n Center A D Club u N Barn O e Bike NIT Harmony R The W SHC GU DO O Bridge Shop LA House Sterling IN C Annex S Quad T Rogers Y R West Dinkel- Bowman D W Black T E T Kresge spiel Alumni O House L Residences B Aud Braun Aud B Lagunita B O A Music Ctr Court Tresidder R Rains East Residences Union SANTA TERESA
    [Show full text]
  • Military Contracting in Silicon Valley Author(S): THOMAS HEINRICH Source: Enterprise & Society, Vol
    Cold War Armory: Military Contracting in Silicon Valley Author(s): THOMAS HEINRICH Source: Enterprise & Society, Vol. 3, No. 2 (JUNE 2002), pp. 247-284 Published by: Cambridge University Press Stable URL: https://www.jstor.org/stable/23699688 Accessed: 22-08-2018 18:59 UTC JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For more information about JSTOR, please contact [email protected]. Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at https://about.jstor.org/terms Cambridge University Press is collaborating with JSTOR to digitize, preserve and extend access to Enterprise & Society This content downloaded from 131.94.16.10 on Wed, 22 Aug 2018 18:59:26 UTC All use subject to https://about.jstor.org/terms Cold War Armory: Military Contracting in Silicon Valley THOMAS HEINRICH Silicon Valley is frequently portrayed as a manifestation of postin dustrial entrepreneurship, where ingenious inventor-businessmen and venture capitalists forged a dynamic, high-tech economy unen cumbered by government's "heavy hand." Closer examination re veals that government played a major role in launching and sustain ing some of the region's core industries through military contracting. Focusing on leading firms in the microwave electronics, missile, satellite, and semiconductor industries, this article argues that de mand for customized military technology encouraged contractors to embark on a course of flexible specialization, batch production, and continuous innovation.
    [Show full text]
  • VARIAN MEDICAL SYSTEMS, INC. (Exact Name of Registrant As Specified in Its Charter)
    FINANCIAL HIGHLIGHTS Dollars in millions, except per share amounts 2016 2015 2014 REVENUES $ 3,218 $ 3,099 $ 3,050 GROSS MARGIN $ 1,361 $ 1,283 $ 1,302 OPERATING EARNINGS $ 551 $ 549 $ 571 OPERATING EARNINGS (as a percentage of revenues) 17.1% 17.7% 18.7% NET EARNINGS ATTRIBUTABLE TO VARIAN $ 402 $ 411 $ 404 NET EARNINGS PER DILUTED SHARE $ 4.19 $ 4.09 $ 3.83 GROSS ORDERS $ 3,400 $ 3,619 $ 3,527 BACKLOG $ 3,453 $ 3,475 $ 3,170 ORDERS & REVENUES COMBINED BUSINESSES ONCOLOGY SYSTEMS IMAGING COMPONENTS OTHER BUSINESS 4000 3000 800 350 3500 700 300 2500 3000 600 250 2000 2500 500 200 2000 1500 400 150 1500 300 1000 100 1000 200 500 50 500 100 0 0 0 0 FY16 FY15 FY14 FY16 FY15 FY14 FY16 FY15 FY14 FY16 FY15 FY14 Gross Orders Revenues EARNINGS BACKLOG 600 3500 500 400 300 3000 200 100 0 2500 FY16 FY15 FY14 Q1 Q2 Q3 Q4 Operating Earnings 2016 2015 2014 Net Earnings Attributable to Varian TO OUR STOCKHOLDERS Fiscal year 2016 was exciting for Varian. In May, we announced plans to separate our Imaging Components business into Varex Imaging Corporation, a new independent public company, through a distribution to Varian stockholders early in fiscal year 2017. Our intent with this separation is to enable our oncology and imaging components businesses to optimize their operations and focus more sharply on the unique needs of customers in their respective markets. You may recall that Varian Medical Systems is itself the product of a successful spin-off that unlocked a tremendous amount of value in three businesses.
    [Show full text]
  • Varian Associates Records, 1948-1998
    http://oac.cdlib.org/findaid/ark:/13030/kt7f59q4cp No online items Finding Aid to the Varian Associates Records, 1948-1998 Processed by Elia Van Lith; additions by Alison E. Bridger The Bancroft Library. University of California, Berkeley Berkeley, California, 94720-6000 Phone: (510) 642-6481 Fax: (510) 642-7589 Email: [email protected] URL: http://bancroft.berkeley.edu © 2007 The Regents of the University of California. All rights reserved. Finding Aid to the Varian BANC MSS 73/65 c 1 Associates Records, 1948-1998 Finding Aid to the Varian Associates Records, 1948-1998 Collection number: BANC MSS 73/65 c The Bancroft Library University of California, Berkeley Berkeley, California Contact Information: The Bancroft Library. University of California, Berkeley Berkeley, California, 94720-6000 Phone: (510) 642-6481 Fax: (510) 642-7589 Email: [email protected] URL: http://bancroft.berkeley.edu Collection Processed By: Elia Van Lith; additions by Alison E. Bridger Date Completed: July 2003; additions January 2007 Finding Aid written by: Elia Van Lith; edited by Alison E. Bridger © 2007 The Regents of the University of California. All rights reserved. Collection Summary Collection Title: Varian Associates Records, Date: 1948-1998 Collection Number: BANC MSS 73/65 c Creator: Varian Associates Extent: Number of containers: 5 cartons and 2 oversize foldersLinear feet: 6.35 Repository: The Bancroft Library Berkeley, California 94720-6000 Abstract: The Varian Associates Records, 1948-1998, document the history of this innovative and successful Silicon Valley pioneer from its inception in 1948 until just prior to its division into three separate companies in 1999. The bulk of the collection consists of minutes from the meetings of the board of directors.
    [Show full text]
  • SLAC, Varian to Develop Klystrons for B Factory
    n e r a c i * o n Pn * Events and Happenings cis..J=~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ovAd in the,. SLAC Community F I I I t Nov.-Dec.*By s 1993,s Vol. 4, No. 12 SLAC, Varian to Develop Klystrons for B Factory SLAC AND VARIAN ASSOCIATES, designs will use standard technol- Inc., a Palo Alto-based, high- ogy, and the other will incorporate technology electronics firm, an- advanced technologies developed nounced recently that they will by Varian. According to SLAC Pro- work together to design and test a ject Manager Robert Phillips, "We klystron tube to be used for the B will build one of each type, and factory. Klystrons, which are perhaps a mix of the two types advanced microwave tubes, are will be used in the B factory." the primary source of power in "Collaboration with Varian particle accelerators. Klystron makes good sense because we can tubes create a very high-frequency work closely together to include electric field, which is used to manufacturing and operational speed up the particles in an accel- efficiencies in the design process," erator. There are about 245 kly- said Phillips. "Varian's participa- stron tubes along the linac. tion can provide alternative tech- The $1.5 million agreement nologies, with which SLAC has states that SLAC and Varian will limited experience, to better opti- develop two different models of mize the klystron." 1200-kilowatt klystrons, one of Varian is also enthusiastic about which will be used in the B facto- the arrangement; the Cooperative ry. The prototype designs will be Research and Development Agree- Andy Nguyen, a senior klystron tube similar to an already-existing 500- ment, which the two organizations technician, with a prototype 500-kilo- kilowatt klystron built and tested watt klystron.
    [Show full text]
  • ROD for Hewlett-Packard
    SFUND RECORDS CTR 44335 RECORD OF DECISION Hewlett-Packard 640 Page Mill Road Superfund Site Palo Alto, California EPA ID/ CAD980884209 PART I - DECLARATION Statement of Basis and Purpose This Record of Decision (ROD) presents the selected remedial action for the Hewlett-Packard 640 Page Mill Road Superfund site (HP-640 PMR) in Palo Alto, California. This document was developed in accordance with the Comprehensive Environmental Response, Compensation and Liability Act of 1980 (CERCLA), as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA), 42 U.S.C. S 9601 et seg., and, to the extent practicable, in accordance with the National Oil and Hazardous Substances Pollution Contingency Plan (NCP), 40 C.F.R. Part 300, and the laws of the State of California. This decision is based on the Administrative Record for the site. The Administrative Record Index appended to this ROD identifies the documents upon which the selection of the remedial action is based. The State of California Regional Water Quality Control Board (RWQCB) is the lead agency that has been responsible for overseeing the Remedial Investigation and Feasibility Study (RI/FS) for this site. The state has finalized its selection of a remedial action for the site in the RWQCB Site Cleanup Requirements (SCRs). With this Record of Decision, the U.S. Environmental Protection Agency (EPA) selects and concurs with the remedy chosen in the RWQCB SCRs. Assessment of the Site Actual or threatened releases of hazardous substances from the HP-640 PMR site, if not addressed by implementing the response action selected in this ROD, may present an imminent and substantial endangerment to public health, welfare or the environment.
    [Show full text]
  • Agilent Technologies, Inc
    AGILENT TECHNOLOGIES, INC. ANNUAL REPORT TO STOCKHOLDERS ANNUAL REPORT CONSOLIDATED FINANCIAL STATEMENTS 2010 Annual Report ANNUAL REPORT TO STOCKHOLDERS ANNUAL REPORT CONSOLIDATED FINANCIAL STATEMENTS 2010 This page is intentionally left blank. To our shareholders, Fiscal 2010 was a strong year for Agilent. Annual revenues were up almost $1 billion from fiscal 2009, an increase of 21 percent. Operating profit and earnings per share also increased substantially. In addition to benefiting from the acquisition of Varian which closed mid-year, we also saw very healthy organic growth in each of our businesses. Overall, Agilent is capitalizing well on the market upturn as the global economy recovers. Annual Report In addition to our strong fiscal 2010 financial results, we completed several strategic milestones. We executed a major restructuring of our electronic measurement business group. We completed the acquisition of Varian, the largest acquisition in our history, to strengthen our bio- analytical businesses. And we established a new business group to focus on the pursuit of the life science market, our largest measurement opportunity in the coming years. Electronic Measurement Group Agilent’s Electronic Measurement Group (EMG) provides solutions in communications, industrial, aerospace and defense, semiconductor and computer measurement markets. As the company’s oldest and most established business, EMG’s heritage dates back more than 70 years to the founding of Agilent’s predecessor company, Hewlett-Packard. Core technology platforms include oscilloscopes, signal analyzers, spectrum analyzers and network analyzers. Electronic Measurement was the business most affected by the 2009 economic recession, due to its exposure to the industrial and consumer markets. Agilent’s management team took proactive actions as early as late 2008 to ensure EMG’s health through the economic downturn.
    [Show full text]
  • Slac Beam Line
    SLAC BEAM LINE Special Issue, Number 2 April 1983 -ANINF'ORMALHISTORYOFSLAC- PARTONE:EARLYACCELERATORWORKATSTANFORD by Edward L. Ginzton a W.W. HANSEN WITH HIS FIRST OPERATING LINEAR ACCELERATOR The story of linear electron accelerators goes back nearly 50 years at Stanford and is particularly entwined with one man, Bill Hansen, shown above with his first operating linear accelerator. 2 SLdC Beam Line, April 1983 EARLY ACCELERATOR WORK AT STANFORD Edward L. Ginzton I am pleased to be back at Stanford and to par- be able to fill in the gaps. ticipate in the SLAC Anniversary Celebration. As many I mentioned already the Blue Book and the com- of you know, the early period of accelerator develop prehensive record of events it provides. I am also aware ment has been central in much of my life, and I should of the content of the talk which Professor Panofsky will like to share with you some of my recollections. Many give later on today. These and other sources provide of you participated in bringing about the success of you a chronicle of events and describe some of the major SLAC; others have worked on the Mark III accelerator obstacles which had to be overcome along the way. For and remember the early period of this development as it one reason or another, the historical accounts I have demonstrated the utility of linear electron accelerators seen-complete as they may be-do not mention the for a variety of applications. periods of joy when luck went our way nor periods of My involvement in this activity goes back to about anguish or despair at other times.
    [Show full text]
  • Weston Anderson Papers 158 Finding Aid Created and Encoded Into EAD by Kenton G
    Weston Anderson Papers 158 Finding aid created and encoded into EAD by Kenton G. Jaehnig.. Last updated on April 26, 2021. Science History Institute Archives Weston Anderson Papers Table of Contents Summary Information....................................................................................................................................3 Biography/History..........................................................................................................................................4 Scope and Contents....................................................................................................................................... 5 Administrative Information........................................................................................................................... 5 Related Materials........................................................................................................................................... 6 Controlled Access Headings..........................................................................................................................6 Collection Inventory...................................................................................................................................... 8 Series I. Notebooks..................................................................................................................................8 Series II. Printed Materials....................................................................................................................10
    [Show full text]
  • The Origins of Silicon Valley: Why and How It Happened Here
    “The Origins of Silicon Valley” August 11, 2016 Talk at Flash Memory Summit The Origins of Silicon Valley: Why and How It Happened Here Paul Wesling , H-P (re tire d), IEEE Life Fe llow Past Communications Director, IEEE SF Bay Area Council Presented at the Flash Memory Summit August 11, 2016 or … You Are There! A step back through Santa Clara Valley and SF Bay Area history 1 “The Origins of Silicon Valley” August 11, 2016 Talk at Flash Memory Summit Classic Silicon Valley: 1976 1975, MP; Gordon French garage; O Homebrew Computer Club – Hobbyists meeting in Menlo Park and at SLAC – Steve Wozniak and Steve Jobs – The Apple I (to sell to friends) Classic Silicon Valley: 1976 Wozniak-Jobs partnership – called it “Apple Computer Company” – Start ed i n a garage iiLn Los Altos – Now has largest stock market capitalization – Most valuable brand in the world How could this happen? Why in the SF Bay Area? 2 “The Origins of Silicon Valley” August 11, 2016 Talk at Flash Memory Summit Before 1900 … The Santa Clara Mission “Valley of the Heart’s Delight” Before 1900 This was more typical … 3 “The Origins of Silicon Valley” August 11, 2016 Talk at Flash Memory Summit Let’s Go Back … Federal Telegraph – Formed in 1909 in Palo Alto (by Cyril Elwell, a Stanf ord grad) – Lee de Forest invented the audion oscillator and amplifier in 1907 – Pioneered continuous- wave radio De Forest tube Federal Telegraph – Paulsen Arc Transmitter, 1909 . Demonstrated sending CW and voice – Raised funds from “angel investors”, including David Starr Jordan, Stanford’s president – Demonstrated communication from S.F.
    [Show full text]
  • Varian Associates and the Birth of Commercial NMR Spectroscopy
    Journal of Magnetic Resonance 306 (2019) 12–16 Contents lists available at ScienceDirect Journal of Magnetic Resonance journal homepage: www.elsevier.com/locate/jmr Varian Associates and the birth of commercial NMR spectroscopy Gareth A. Morris School of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK article info abstract Article history: The birth and early growth of commercial NMR instrumentation, and the parts played by the brothers Received 1 April 2019 Russell and Sigurd Varian and their colleagues, are described. Revised 18 April 2019 Ó 2019 Elsevier Inc. All rights reserved. Accepted 8 July 2019 Available online 9 July 2019 Keywords: Varian NMR History 1. Introduction the limitations of the navigation systems then available. In the mid 1930s the two brothers left their jobs and set up a laboratory We think of Silicon Valley as a modern phenomenon – the rapid together in Halcyon, where they worked on developing a growth of businesses in the Santa Clara Valley near San Francisco, microwave-based system for locating aeroplanes, in part moti- starting in the 1970s, based first on semiconductor technology, and vated by Sigurd’s concern at the dangers posed by aerial warfare subsequently on the myriad uses to which such technology can be and the rise of fascism. A request for help to a friend of Russell’s, put. The changes in society that this small geographical region has Stanford professor William Hansen, led to their relocation to the brought about are proving as far-reaching as those of the Industrial Physics department at Stanford, and eventually to the develop- Revolution, which began in the area around Manchester in the ment of the klystron.
    [Show full text]